XML 17 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Tables)
3 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Stock Based Compensation Included in Consolidated Statements of Operations
The amounts included in the consolidated statements of operations related to stock-based compensation are as follows (dollars in thousands): 
 
Three Months Ended December 31,
2019
 
2018
Cost of hosting and professional services
$
5,541

 
$
6,957

Cost of product and licensing
129

 
264

Cost of maintenance and support
393

 
(234
)
Research and development
8,704

 
5,376

Sales and marketing
7,028

 
8,252

General and administrative
9,438

 
8,882

Total
$
31,233

 
$
29,497


Summary of Stock Options Activity
The table below summarizes activities related to stock options for the three months ended December 31, 2019:
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value (a)
Outstanding at September 30, 2019
11,302

 
$
20.04

 
 
 
 
Exercised
(3,207
)
 
$
17.18

 
 
 
 
Expired

 
$

 
 
 
 
Equitable Adjustment - Cerence Spin-off (b)
1,883

 
 
 
 
 
 
Outstanding at December 31, 2019
9,978

 
$
17.18

 
2.3 years
 
$

Exercisable at December 31, 2019
9,978

 
$
17.18

 
2.3 years
 
$

Exercisable at December 31, 2018
14,616

 
$
17.13

 
2.9 years
 
$

(a) 
The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2019 ($17.83) over the exercise price of the underlying options.
Summary of Activity Relating to Restricted Units and Restricted Stock Awards he table below summarizes activities relating to restricted units for the three months ended December 31, 2019:
 
Number of Shares Underlying Restricted Units — Performance-Based Awards
 
Number of Shares Underlying Restricted Units — Time-Based Awards
Outstanding at September 30, 2019
1,991,325

 
8,998,944

Granted
1,060,384

 
3,934,253

Earned/released
(303,198
)
 
(5,274,466
)
Forfeited
(418,834
)
 
(1,253,558
)
Equitable Adjustment - Cerence Spin-off (b)
303,074

 
1,316,006

Outstanding at December 31, 2019
2,632,751

 
7,721,179

Weighted average remaining recognition period of outstanding Restricted Units
2.1 years

 
1.9 years

Unrecognized stock-based compensation expense of outstanding Restricted Units
$27.2 million
 
$74.2 million
Aggregate intrinsic value of outstanding Restricted Units (a)
$46.9 million
 
$137.7 million
                    
(a) 
The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2019 ($17.83) over the purchase price of the underlying restricted units.
(b) 
Effective with the spin-off of Automotive on October 1, 2019, outstanding equity awards were equitably adjusted by a conversion ratio of 1.16667 per one Nuance share then held.
Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units and Restricted Stock Awards Vested summary of the weighted-average grant-date fair value of restricted units granted, and the aggregate intrinsic value of restricted units vested during the periods noted is as follows: 
 
Three Months Ended December 31,
2019
 
2018
Weighted-average grant-date fair value per share
$
17.08

 
$
16.43

Total intrinsic value of shares vested (in millions)
$
95.4

 
$
82.4

Performance-based restricted units outstanding as of December 31, 2019 and issued in fiscal year 2019 include performance goals based on total shareholder return relative to our peers during the performance period. The awards actually earned will be up to two hundred percent of the target number of the performance-based Restricted Units. Compensation expense is recorded ratably over the performance period of the award based on the estimated grant date fair value estimated at the grant date using a Monte Carlo simulation model, which included the following assumptions:
 
December 31, 2019
 
December 31, 2018
Dividend yield
0.0
%
 
0.0
%
Expected volatility
27.73
%
 
27.86% - 30.85%

Risk-free interest rate
1.62
%
 
2.72% - 3.02%

Expected term (in years)
3

 
1 - 3